Back to Capital International Investors Capital International Investors

ONCONC
Showing 8 of 31 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in BEONE MEDICINES LTD

Yes. Capital International Investors holds 4,210,221 shares of ONC (BeOne Medicines), worth $1.2B, as of its Q2 2026 13F filing. It increased the position by 51,495 shares (+1.2%) from Q1 2026. Capital International Investors has held ONC in every 13F on record since Q4 2018, 31 quarterly filings. ONC is 0.2% of Capital International Investors' reported 13F portfolio.

Current Value

$1.2B

Current Shares

4.2M

Total Value Change

-$240.2M

Total Shares Change

-2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.2M
+1.2%
$1.2B0.2%$284.97
39
2026-Q1
Decreased
4.2M
-18.7%
$1.2B0.3%$296.97
0
2025-Q4
Increased
5.1M
+1.3%
$1.6B0.2%$303.81
39
2025-Q3
Increased
5M
+3.3%
$1.7B0.3%$340.70
39
2025-Q2
Decreased
4.9M
-4.0%
$1.2B0.2%$242.07
0
2025-Q1
Decreased
5.1M
-16.7%
$1.4B0.3%$272.17
0
2024-Q4
Decreased
6.1M
-4.9%
$1.1B0.2%$184.71
0
2024-Q3
Decreased
6.4M
-8.3%
$1.4B0.3%$224.51
0

Other major holders of ONC: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used